Atlas Trials

Efficacy and Safety of MCS-2 in the Treatment of Lower Urinary Tract Symptoms

Clinical trial NCT01002664 · COMPLETED

Trial details

NCT number
NCT01002664
Sponsor
Health Ever Bio-Tech Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lower Urinary Tract SymptomsBenign Prostatic Hyperplasia
Start date
2010-05-01
Primary completion
2014-06-01
Enrollment
272

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.